Evome Medical Technologies (Evome Medical Technologies) Asset Impairment Charge : $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Evome Medical Technologies Asset Impairment Charge?

Evome Medical Technologies's Asset Impairment Charge for the three months ended in Dec. 2023 was $0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.

Evome Medical Technologies Asset Impairment Charge Historical Data

The historical data trend for Evome Medical Technologies's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evome Medical Technologies Asset Impairment Charge Chart

Evome Medical Technologies Annual Data

Trend

Dec14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

0.07

4.35

4.34

10.07

Evome Medical Technologies Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Mar23	Jun23	Sep23	Dec23
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Evome Medical Technologies Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Evome Medical Technologies Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Evome Medical Technologies's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.